Targeting the oncogene and kinome chaperone CDC37.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 18511936.
- Also identified by DOI 10.1038/nrc2420 and PMC identifier 2779120.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
CDC37 is a molecular chaperone that physically stabilizes the catalytic domains found in protein kinases and is therefore a wide-spectrum regulator of protein phosphorylation. It is also an overexpressed oncoprotein that mediates carcinogenesis by stabilizing the compromised structures of mutant and/or overexpressed oncogenic kinases. Recent work shows that such dependency of malignant cells on increased CDC37 expression is a vulnerability that can be targeted in cancer by agents that deplete or inhibit CDC37. CDC37 is thus a candidate for broad-spectrum molecular cancer therapy.
Medical subject headings
- Antineoplastic Agents
- Cell Cycle Proteins
- Chaperonins
- Oncogenes